Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Comment by Stranius75on Jun 07, 2018 6:12pm
72 Views
Post# 28142338

RE:Positive news that affects LDS

RE:Positive news that affects LDS

Crash or cash: What’s happening to California cannabis prices?

At a high-end dispensary in San Francisco, the self-proclaimed center of all things disruptive, staffers are debating if the time is right to unleash onto the market something never before seen, something they believe could revolutionize California’s multibillion-dollar marijuana industry.

They’re wondering whether they can charge $90 for an eighth of an ounce of cannabis—and if customers will still buy it.

“People don’t blink at $75 an eighth,” said one of the dispensary’s buyers, who requested anonymity in order to speak freely. That, in turn, is fueling the high-roller’s urge to push the stakes even higher. “Is $90 an eighth insane?”


Bullboard Posts